Overview

CYP 2C19 Polymorphism and Voriconazole Trough Concentration in Chinese Adult Patients

Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
To investigate the relationship between cytochrome P450 (CYP) 2C19 genetic polymorphism and the steady-state blood concentration of voriconazole in Chinese patients with invasive pulmonary aspergillosis (IPA), and to assess the effects of voriconazole trough concentration on the prognosis of IPA patients.
Details
Lead Sponsor:
dingshifang
Collaborators:
Jinan Central Hospital
Jinan Military General Hospital
Qianfoshan Hospital
Shandong Provincial Hospital
Shandong thorax hospital
Treatments:
Voriconazole